GALT vs GILD: Which Stock is Better?
Side-by-side comparison of Galectin Therapeutics Inc and Gilead Sciences Inc in 2026
GALT
Galectin Therapeutics Inc
$2.45
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | GALT | GILD | Winner |
|---|---|---|---|
| Market Cap | $161.28M | $171.97B | GILD |
| P/E Ratio | N/A | 20.44 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze GALT
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GALT or GILD a better investment?
Comparing GALT and GILD: Galectin Therapeutics Inc has a market cap of $161.28M while Gilead Sciences Inc has $171.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GALT and GILD?
GALT (Galectin Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GALT or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: GALT or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for GALT.
Which company is more profitable: GALT or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for GALT.
Which is the larger company: GALT or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $171.97B compared to $161.28M for GALT.
Should I buy GALT or GILD in 2026?
Both GALT and GILD have investment merit. GALT trades at $2.45 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GALT and GILD stock?
Key differences: Market Cap ($161.28M vs $171.97B), P/E Ratio (N/A vs 20.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).